ABSCINT
A clinical stage molecular imaging company developing in-vivo diagnostics based on single domain antibodies. Learn more
Launch date
Employees
Market cap
-
Enterprise valuation
$13—20m (Dealroom.co estimates Sep 2023.)
Company register number 0749.828.410
Ganshoren Brussels-Capital (HQ)
Authorizing premium user...